Tashkent, Uzbekistan (UzDaily.com) —  The Assembly of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is currently taking place in Montreal, marking a significant event in global pharmaceutical regulatory affairs.

Representing Uzbekistan at the meeting is Alisher Temirov, Director of the State Institution "Pharmaceutical Product Safety Center" under the Ministry of Health. This marks the first-ever participation of a delegation from the Center in such an important international forum.

For reference: ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) was founded in 1990 and works on developing unified standards to ensure the safety, quality, and effectiveness of medicines. Today, ICH includes 19 full members and 36 observers, with key global regulators such as the USA, the European Union, Japan, and other international organizations.

In his report, Alisher Temirov presented the activities of Uzbekistan’s national regulator and its contributions to ensuring the safety and quality of pharmaceutical products in the country. His speech was highly appreciated by the participants, and the Council unanimously decided to grant the State Institution "Pharmaceutical Product Safety Center" official observer status at ICH.

It is important to note that obtaining observer status at ICH is not just an achievement but a significant step toward Uzbekistan’s international integration into the pharmaceutical community. This opens up new opportunities for harmonizing national regulatory standards with international requirements and strengthening the country’s position on the global stage.